Published Date: 02 Mar 2023
The latest studies of long-acting ART show benefits even in people who are not immune. Meanwhile, early proof-of-concept results for twice-yearly injection are encouraging.
Read Full News1.
Study: Elinzanetant cuts vasomotor symptoms in women with breast cancer on endocrine therapy
2.
Oleanolic acid from grapes may increase chemotherapy effectiveness
3.
New CAR T-Cell Therapy Approved for Leukemia
4.
Children living near oil and gas wells face higher risk of rare leukemia, studies show
5.
After cancer: Study explores caring-healing modalities for survivors
1.
Liquid Biopsy: A Revolutionary Tool for Early Detection and Monitoring of Colorectal Cancer
2.
Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership
3.
Unveiling the Mysteries of Smudge Cells: A New Frontier in Cellular Biology
4.
KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer
5.
Gene Signatures and Their Implications in Oncology: Decoding the Blueprint for Personalized Cancer Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
4.
Rates of CR/CRi and MRD Negativity in Iontuzumab-Treated Patients
5.
Thromboprophylaxis In Medical Settings
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation